Nuvation Bio Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Nuvation Bio Inc. (NUVB), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are NUVB insiders buying or selling?
In the last 12 months, Nuvation Bio Inc. insiders reported 1 open-market purchase ($118.3K) and 14 sales ($9.7M) — net selling of $9.6M. Since July 2020, Trabud has recorded 41 Form 4 filings for NUVB: 19 buys ($32.2M) and 22 sells ($74.2M).
Source: SEC EDGAR Form 4
Key Statistics (July 2020 – Aug 21, 2026)
Total Form 4 filings
41
SEC EDGAR
Insider filers
17
Insider buys (19)
$32.2M
Insider sells (22)
$74.2M
Insider sentiment
Net sellingNet insider flow of $41.9M in net selling since July 2020, and $9.6M in net selling over the last 12 months.
Recent NUVB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale | 100.0K | $7.09 | $709.2K | SEC ↗ |
| Jun 24, 2026 | Stacy Markel | CHIEF PEOPLE OFFICER | Sale | 125.0K | $6.03 | $753.2K | SEC ↗ |
| Jun 24, 2026 | Kerry Wentworth | CHIEF REGULATORY OFFICER | Sale | 63.0K | $6.02 | $379.2K | SEC ↗ |
| Jun 24, 2026 | Philippe Sauvage | Chief Financial Officer | Sale | 47.7K | $6.01 | $286.4K | SEC ↗ |
| Jun 12, 2026 | Robert Mashal | Director | Purchase | 25.0K | $4.73 | $118.3K | SEC ↗ |
| Apr 21, 2026 | Kerry Wentworth | CHIEF REGULATORY OFFICER | Sale | 36.8K | $5.01 | $184.3K | SEC ↗ |
| Apr 21, 2026 | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale | 50.0K | $5.02 | $251.0K | SEC ↗ |
| Apr 8, 2026 | Kerry Wentworth | CHIEF REGULATORY OFFICER | Sale | 200.0K | $4.52 | $903.6K | SEC ↗ |
| Dec 3, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale | 150.0K | $7.82 | $1.2M | SEC ↗ |
| Nov 26, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale | 20.0K | $7.75 | $155.0K | SEC ↗ |
| Nov 24, 2025 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale | 369.1K | $7.23 | $2.7M | SEC ↗ |
| Nov 24, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale | 20.0K | $7.00 | $140.1K | SEC ↗ |
| Nov 21, 2025 | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Sale | 200.0K | $7.14 | $1.4M | SEC ↗ |
| Nov 19, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale | 30.0K | $4.93 | $148.0K | SEC ↗ |
| Oct 29, 2025 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale | 100.0K | $5.02 | $502.5K | SEC ↗ |
| Jun 18, 2025 | Stacy Markel | CHIEF PEOPLE OFFICER | Purchase | 10.0K | $1.71 | $17.1K | SEC ↗ |
| Jun 18, 2025 | Philippe Sauvage | Chief Financial Officer | Purchase | 7.3K | $1.81 | $13.2K | SEC ↗ |
| Jun 18, 2025 | Colleen Sjogren | Chief Commercial Officer | Purchase | 50.0K | $1.81 | $90.3K | SEC ↗ |
| Jun 18, 2025 | Kerry Wentworth | CHIEF REGULATORY OFFICER | Purchase | 50.0K | $1.79 | $89.7K | SEC ↗ |
| Jun 18, 2025 | Hung David | PRESIDENT AND CEO | Purchase | 500.0K | $1.79 | $893.5K | SEC ↗ |
| May 6, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale | 20.0K | $2.50 | $50.0K | SEC ↗ |
| Apr 9, 2025 | Hung David | PRESIDENT AND CEO | Purchase | 500.0K | $1.64 | $820.2K | SEC ↗ |
| Apr 3, 2025 | Robert Mashal | Director | Purchase | 100.0K | $1.67 | $167.0K | SEC ↗ |
| Nov 13, 2024 | Junyuan Jerry Wang | CEO, ANHEART THERAPEUTICS LTD. | Sale | 56.4K | $2.89 | $162.9K | SEC ↗ |
| Oct 10, 2024 | Robert Mashal | Director | Purchase | 100.0K | $2.20 | $220.0K | SEC ↗ |
Showing the 25 most recent of 41 Form 4 filings for Nuvation Bio Inc..
Most active NUVB insiders
- Dongfang Liu6 filings
- Omega Fund V, L.P.6 filings
- Kerry Wentworth4 filings
- Oleg Nodelman4 filings
- Gary Hattersley3 filings
Ask anything about NUVB insider activity
Use Trabud's AI agent to query Nuvation Bio Inc.'s Form 4 history in plain English — "Show me NUVB CEO purchases this year" or compare it against any other ticker.
Open the AI agentNUVB insider trading FAQ
Are Nuvation Bio Inc. insiders buying or selling?
In the last 12 months, Nuvation Bio Inc. insiders reported 1 open-market purchase ($118.3K) and 14 sales ($9.7M) — net selling of $9.6M. Since July 2020, Trabud has recorded 41 Form 4 filings for NUVB: 19 buys ($32.2M) and 22 sells ($74.2M). Over the full record that is net selling of $41.9M.
How many insiders trade NUVB stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Nuvation Bio Inc.. The most recent filing was accepted on Aug 21, 2026.
Where does Trabud get NUVB insider trading data?
All NUVB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.